Company intelligence
DrugPatentWatch Pharmaceutical Drug Patent Intelligence
Find Your Next Blockbuster - Your single platform for accurate, objective, and timely intelligence
About DrugPatentWatch Pharmaceutical Drug Patent Intelligence
Global biopharmaceutical drug patent and generic entry business intelligence. DrugPatentWatch Supports Critical Business Decisions: >Payers: Formulary and pharmacy & therapeutics (P&T) Anticipate future budget requirements and proactively identify generic sources > Branded pharmaceutical manufacturers Assess past successes of patent challengers and elucidate research paths of competitors > Generic manufacturers Inform portfolio management decisions on future drug development > Buyers, wholesalers, and distributors Predict branded drug patent expiration, identify generic suppliers, and prevent overstock of branded drugs > API manufacturers Obtain formulation and manufacturing information; identify final formulators, repackagers, and relabellers
Verified activity
Signals from DrugPatentWatch Pharmaceutical Drug Patent Intelligence
6 published signals
Legal & Regulatory
DrugPatentWatch Pharmaceutical Drug Patent Intelligence identified the litigation summary for Ultragenyx Pharmaceutical Inc. v. Navinta LLC, No. 2:26-cv-03585, a patent infringement dispute filed in the District of New Jersey.
Reported by DrugPatentWatch Pharmaceutical Drug Patent Intelligence
Legal & Regulatory
DrugPatentWatch Pharmaceutical Drug Patent Intelligence reported that Vertex Pharmaceuticals Incorporated sued MSN Pharmaceuticals Inc. in the US District Court for the District of Delaware under docket 1:26-cv-00306, focusing on Vertex's patent and regulatory exclusivity position for a product in the payer- and formulary-critical segment.
Reported by DrugPatentWatch Pharmaceutical Drug Patent Intelligence
Products & Services
DrugPatentWatch Pharmaceutical Drug Patent Intelligence built DrugChatter.com to see how AI is talking about medicines today and identify risks.
Reported by Yali Friedman, PhD
Research & Knowledge
DrugPatentWatch Pharmaceutical Drug Patent Intelligence published a discussion analyzing how generic patent challenges interact with the Hatch-Waxman framework and the timing of patent litigation.
Reported by Yali Friedman, PhD
Research & Knowledge
DrugPatentWatch Pharmaceutical Drug Patent Intelligence is exploring human-AI collaboration at DrugChatter.com.
Reported by Yali Friedman, PhD
Legal & Regulatory
DrugPatentWatch Pharmaceutical Drug Patent Intelligence reported that the new patent expiration for B Braun drug CLOROTEKAL is due in 2026.
Reported by Yali Friedman, PhD